|
| 36477975 | Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML. | Blood Adv | 2023 |
| 35091442 | Phase II Study of Ponatinib in Advanced Gastrointestinal Stromal Tumors: Efficacy, Safety, and Impact of Liquid Biopsy and Other Biomarkers. | Clinical Cancer Research | 2022 |
| 30042204 | Single-Molecule Sequencing Reveals Patterns of Preexisting Drug Resistance That Suggest Treatment Strategies in Philadelphia-Positive Leukemias. | Clin Cancer Res | 2018 |
| 26603839 | Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients. | Blood | 2016 |
| 26773037 | The impact of multiple low-level BCR-ABL1 mutations on response to ponatinib. | Blood | 2016 |
| 23172372 | Expression of miR-124 inhibits growth of medulloblastoma cells. | Neuro Oncol | 2013 |
| 23836465 | Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer. | Journal of Pathology | 2013 |
| 22860045 | A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterations. | PLoS One | 2012 |
| 22937035 | Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas. | PLoS One | 2012 |
| 22393095 | Identification of a poor-prognosis BRAF-mutant-like population of patients with colon cancer. | Journal of Clinical Oncology | 2012 |
| 22038996 | Targeted therapy for BRAFV600E malignant astrocytoma. | Clin Cancer Res | 2011 |
| 21807965 | Progressive genomic instability in the FVB/Kras(LA2) mouse model of lung cancer. | Mol Cancer Res | 2011 |
| 20093527 | Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging. | Radiology | 2010 |
| 20129251 | Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. | Cancer Cell | 2010 |
| 20169192 | A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen. | PLoS One | 2010 |
| 20068183 | Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas. | Cancer Res | 2010 |
| 19843846 | Whole-body sleeping beauty mutagenesis can cause penetrant leukemia/lymphoma and rare high-grade glioma without associated embryonic lethality. | Cancer Res | 2009 |
| 19139420 | Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts. | Neuro Oncol | 2009 |
| 19731102 | microRNAs in gliomas: small regulators of a big problem. | NeuroMolecular Medicine | 2009 |
| 18522749 | Mammary carcinoma behavior is programmed in the precancer stem cell. | Breast Cancer Res | 2008 |
| 18577219 | miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. | BMC Med | 2008 |
| 16266989 | Copy number aberrations in mouse breast tumors reveal loci and genes important in tumorigenic receptor tyrosine kinase signaling. | Cancer Res | 2005 |
| 15867356 | Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8. | Cancer Res | 2005 |
| 16132578 | Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior. | Clin Exp Metastasis | 2005 |
| 14744772 | The role of p53 in suppression of KSHV cyclin-induced lymphomagenesis. | Cancer Res | 2004 |
| 15283211 | Array comparative genomic hybridization with cyanin cis-platinum-labeled DNAs. | Biotechniques | 2004 |
| 15488760 | Absence of telomerase and shortened telomeres have minimal effects on skin and pancreatic carcinogenesis elicited by viral oncogenes. | Cancer Cell | 2004 |
| 15466197 | Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability. | Cancer Res | 2004 |
| 15169571 | A murine leukemia virus with Cre-LoxP excisible coding sequences allowing superinfection, transgene delivery, and generation of host genomic deletions. | Retrovirology | 2004 |
| 14871825 | TIMP-1 alters susceptibility to carcinogenesis. | Cancer Research | 2004 |
| 15059892 | Oncogene expression and genetic background influence the frequency of DNA copy number abnormalities in mouse pancreatic islet cell carcinomas. | Cancer Res | 2004 |
| 12755492 | Genome amplification of chromosome 20 in breast cancer. | Breast Cancer Res Treat | 2003 |
| 14500357 | Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumors. | Cancer Res | 2003 |
| 12702876 | Induction of tumors in mice by genomic hypomethylation. | Science | 2003 |
| 11133364 | Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo. | American Journal of Human Genetics | 2001 |
| 11694878 | Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. | Nat Genet | 2001 |
| 10402204 | A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. | Neuron | 1999 |
| 10434304 | Evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease in cell culture and in transgenic mice expressing mutant huntingtin. | Philos Trans R Soc Lond B Biol Sci | 1999 |
| 8702625 | Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme. | Journal of Biological Chemistry | 1996 |
| 8968738 | Human huntingtin derived from YAC transgenes compensates for loss of murine huntingtin by rescue of the embryonic lethal phenotype. | Human Molecular Genetics | 1996 |